Please login to the form below

Not currently logged in
Email:
Password:

Gregory Gallo joins Treato as chief commercial officer

Brings experience from Quest Diagnostics and Johnson & Johnson

Treato Gregory GalloIsrael-based Treato has appointed Gregory Gallo as its new chief commercial officer.

Working out of the online healthcare consumer insights firm's Princeton, New Jersey office, Gallo will be responsible for leading its business solutions unit as well as expanding the firm's global presence in the pharmaceutical industry.

Ido Hadari, Treato's chief executive officer, said: “Greg has a remarkable track record in helping build, lead and scale innovative businesses.

“We are excited to have Greg join our leadership team and look forward to benefitting from his vast knowledge and commercial experience in the healthcare data and analytics field.”

Gallo has over 20 years of commercial experience in the healthcare and pharmaceutical industries, having held senior roles at IntelliSante, ImpactRX, Johnson & Johnson and Quest Diagnostics.

He joins Treato from Activate Networks, now a part of Decision Resources Group, where he served as chief commercial officer and oversaw its commercial operations and growth.

12th February 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics